Assure Rapid Test for Point-of-Care

Assure COVID-19 IgG/IgM Rapid Test for the detection of IgG and IgM antibodies to SARS-CoV-2 for use in point-of-care setting.

Bulk Discounts Available

Order NowContact Us

First FDA Authorized rapid test for use in Point-of-Care with a fingerstick specimen

CareStart Rapid Antigen Test

The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from individuals who are suspected of COVID-19 by their healthcare providers. This product is CLIA waived under FDA/EUA authorization.

The CareStart™ COVID-19 Antigen test is authorized for use using nasopharyngeal swab specimens collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms.

The CareStart™ COVID-19 Antigen test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

The CareStart™ COVID-19 Antigen test is authorized for use in laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet requirements to perform high, moderate or waived complexity tests.

Assure Antibody Test

Product configuration:  Each box contains 20 individual tests.
Pricing:

$300.00/ box for qty 1-5 boxes
$279.00 for for qty 6-15 boxes
For 16 or more boxes, please contact our sales department at sales@coronachecktest.com or call at (240) 453-6339 

* You must register to purchase this test

Category:

Sales Inquiry